What is the evidence for TB-500?
The first question for TB-500 is entity identity: evidence about full-length thymosin beta-4 should not be treated as direct evidence for every TB-500 product.
DIRECT ANSWER
TB-500 evidence summary.
The first question for TB-500 is entity identity: evidence about full-length thymosin beta-4 should not be treated as direct evidence for every TB-500 product.
Reviewed August 7, 2026. Each statement links to its evidence record, followed by the primary and official sources used for this answer.
Human studies of full-length thymosin beta-4 cannot automatically be transferred to products marketed as TB-500.
Open evidence recordMuch of the cited tissue-repair literature concerns thymosin beta-4 rather than a verified TB-500 product.
Open evidence recordName similarity is not evidence equivalence.
Open evidence recordPRIMARY & OFFICIAL SOURCES
Sources for this answer.
2 source records, with duplicates removed.